Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
494 participants
OBSERVATIONAL
2020-05-28
2021-09-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longitudinal Recovery Trajectories After an Acute Respiratory Distress Syndrome, a New Understanding
NCT06083363
Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19
NCT04586114
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180
Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia
NCT04362345
Clinical Features, Treatments, and Outcomes in Acute Respiratory Distress Syndrome (ARDS-CTO)
NCT07186140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving care at a participating site
* Age 18 years old or older
* U.S. Resident
* Confirmed positive for COVID-19
* Willing and able to comply with all study procedures
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Verily Life Sciences LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charlie Kim, PhD
Role: STUDY_DIRECTOR
Verily Life Sciences LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Arizona
Tucson, Arizona, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
University of Illinois at Chicago
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Weill Cornell Medical College
New York, New York, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
Inova Health Care Services
Falls Church, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
102293
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.